What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Neuron
His scientific interests lie mostly in Pharmacology, GABAA receptor, Receptor, Internal medicine and Endocrinology.
His Pharmacology research incorporates themes from Convulsant, Postsynaptic potential, Mechanism of action, Inhibitory postsynaptic potential and Anticonvulsant.
His GABAA receptor research includes themes of gamma-Aminobutyric acid, Biophysics and Protein subunit.
He interconnects Glycine, Mutant and Gene isoform in the investigation of issues within Receptor.
His work in Internal medicine addresses issues such as Dorsal root ganglion, which are connected to fields such as Dynorphin A, Opioid peptide and -Naloxone.
His biological study spans a wide range of topics, including Agonist and Childhood absence epilepsy.
His most cited work include:
- GABAA Receptor Channels (1761 citations)
- It's Time to Revise the Definition of Status Epilepticus (603 citations)
- Antiepileptic Drug Mechanisms of Action (470 citations)
What are the main themes of his work throughout his whole career to date?
Robert L. Macdonald mostly deals with GABAA receptor, Receptor, Biophysics, Pharmacology and Protein subunit.
Robert L. Macdonald has included themes like gamma-Aminobutyric acid, Endocrinology and Neuroscience in his GABAA receptor study.
His Receptor research is multidisciplinary, relying on both Gating and Gene isoform.
His research integrates issues of Calcium, Electrophysiology, Patch clamp and Biochemistry in his study of Biophysics.
His Pharmacology study combines topics from a wide range of disciplines, such as Anticonvulsant, Convulsant, Postsynaptic potential and Mechanism of action.
His Protein subunit study which covers Molecular biology that intersects with Interleukin 10 receptor, alpha subunit.
He most often published in these fields:
- GABAA receptor (39.88%)
- Receptor (32.74%)
- Biophysics (23.81%)
What were the highlights of his more recent work (between 2010-2021)?
- GABAA receptor (39.88%)
- Protein subunit (20.83%)
- Receptor (32.74%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are GABAA receptor, Protein subunit, Receptor, Epilepsy and Genetics.
The various areas that Robert L. Macdonald examines in his GABAA receptor study include Gene knockin, GABAergic and Ion channel.
The Protein subunit study combines topics in areas such as Mutation, Molecular biology, Mutant and Cell biology.
The concepts of his Receptor study are interwoven with issues in Gating and Drug.
The subject of his Epilepsy research is within the realm of Neuroscience.
His Dravet syndrome study combines topics in areas such as Internal medicine, Endocrinology and Bioinformatics.
Between 2010 and 2021, his most popular works were:
- Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism (84 citations)
- Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome. (52 citations)
- The human epilepsy mutation GABRG2(Q390X) causes chronic subunit accumulation and neurodegeneration (51 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Genetics
His primary areas of investigation include GABAA receptor, Receptor, Protein subunit, Genetics and Mutation.
His biological study deals with issues like Neurotransmission, which deal with fields such as Gephyrin and Protein targeting.
His Receptor research includes elements of Pharmacology and Drug.
In the field of Protein subunit, his study on GABAA-rho receptor overlaps with subjects such as Cys-loop receptors.
His work deals with themes such as Childhood absence epilepsy and Epilepsy, which intersect with Genetics.
His Missense mutation research is multidisciplinary, incorporating perspectives in Myoclonus, Early myoclonic encephalopathy, Internal medicine and Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
